Clinical Trial Update: The Use of Intranasal Ketoralac for Pain Management (Sprix) [Phase 4]

View source ↗

Summary

Phase 4 trial update on intranasal ketorolac (Sprix) for postoperative pain management and urolithiasis, with the study terminated and results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain
• Urolithiasis

Drugs mentioned

• SPRIX (ketorolac tromethamine)

Snippet

Sponsor: Montefiore Medical Center | Conditions: Postoperative Pain Management, Urolithiasis | Phase 4 | Status: TERMINATED | Results posted: 2020-02-13